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Letter to the Editor
Two different tumours in the same
eye
Benign and malignant intraocular pigmented lesions
can share similar clinical and diagnostic signs, posing
a challenge for the clinician ophthalmologist.1 We
report a case of a retinal pigment epithelium (RPE)
adenoma imitating a malignant transformed
melanocytoma at the optic nerve, 10years after treat-
ment of a peripheral choroidal melanoma in the same
eye. According to our knowledge, this is the ﬁrst re-
port of a choroidal melanoma and an RPE adenoma
in the same eye.
A 54-year-old woman was diagnosed with a pe-
ripheral choroidal melanoma in the right eye and
underwent ruthenium plaque radiotherapy. At that
time, a presumed melanocytoma of the optic disc
was documented in the same eye. The left eye was
unremarkable. Ten years after melanoma treatment,
the patient complained about metamorphopsia and
progressive visual loss. On examination, best-
corrected visual acuity was 6/38 oculus dexterQ2 (OD)
and 6/6 oculus sinister (OSQ3 ). The intraocular pressure
was 18mmHg OD and 20mmHg OS. There was no
signiﬁcant change to the pigmented lesion at the right
optic disc compared with previous ﬁndings (Fig.F1 1a).
On ultrasonography, the tumour measured
3.54×3.71mm with a thickness of 1.73mm. The pre-
viously treated choroidal melanoma in the superior
periphery had regressed completely. Six months
later, however, the pigmented tumour at the optic
nerve showed a slight increase in growth, measuring
4.09×3.97mm with a thickness of 1.64mm. A vitrec-
tomy with silicone oil tamponade and a transretinal
biopsy of the presumed melanocytoma with the 25-
gauge vitreous cutter were conducted 8months later
because of an exudative retinal detachment. The cyto-
logical examination suggested a pigmented tumour,
predominantly of small plump cells with oval-
shaped nucleus and with a discrete central nucleolus.
The molecular diagnostics using microsatellite
analysis revealed an allelic imbalance and loss of het-
erozygosity for one of the four examined loci on chro-
mosome 3p as well as for one locus on chromosome
3q, suggestive (but not conclusively) of the diagnosis
of a spindle cell choroidal melanoma.
A further 2months later, the patient re-presented
with a rhegmatogenous retinal re-detachment in the
right eye. Best-corrected visual acuity was hand mo-
tion OD and 6/6 OS. Both eyes were normotensive.
On the grounds of signiﬁcantly reduced vision and
the suggested diagnosis of a malignant transforma-
tion of the presumed melanocytoma into a mela-
noma, enucleation of the right eye was decided on
by the patient.
The enucleation specimen revealed chorioretinal
atrophy at the level of the equator, corresponding to
the area of the previously treated choroidal mela-
noma. At the optic disc, a nodular proliferation of
RPE cells in the form of pseudoglands and trabeculae
was seen (Fig. 1b). Some of the RPE cells were
pigmented Q4. The cells were small-to-medium in size
with ovoid nuclei and prominent nucleoli. Mitoses
were not seen. The lesion was contiguous with the
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Figure 1. Ophthalmoscopic image and histology of the right eye. (a) Ophthalmoscopic image demonstrating the black pigmented tu-
mour at the optic disc and the area of plaque irradiation superiorly. Inset, magniﬁed view of the lesion of concern at the optic disc. (b)
Enucleation specimen showing a chorioretinal atrophy following plaque brachytherapy and a nodular proliferation of the retinal pigment
epithelium (RPE) (arrow) at the optic disc (hematoxylin–eosin, original magniﬁcation × 1.5). Inset, magniﬁed view of the area in the cho-
roidal and retinal atrophy (hematoxylin–eosin, original magniﬁcation × 10).
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adjacent RPE layer. On immunohistochemistry, these
cells were strongly positive for MelanA, Ki-67 and
the cytokeratin stain AE1/AE3 as well as for
CAM5.2 (weak; Fig.F2 2b,c,d). Nuclear staining for
microphthalmia transcription factorQ5 was seen. They
were negative for the cytokeratin markers CK5/6,
CK7 and MNF-116, as well as for the melanocyte
markers SOX10 and HMB-45. These histological
ﬁndings led to the diagnosis of an RPE adenoma at
the optic nerve.
We report a rare case of two different tumour enti-
ties in the same eye. The coexistence of two or more
neoplasms in the same eye is very uncommon and
can be diagnostically challenging.2,3 To date, the
occurrence of an RPE adenoma and a choroidal
melanoma has not been described in the literature.
There are some similarities among RPE adenomas,
choroidal melanocytomas and melanomas; however,
there are usually distinct clinical signs for differenti-
ating these neoplasms.4 Despite this, in some cases,
the differentiation between these entities can be
difﬁcult and requires pathological analysis.
In the present case, it was clear that the peripheral
choroidal tumour was a melanoma and was treated as
such. The initial clinical diagnosis of an additional
optic disc melanocytoma – a benign lesion, which
may enlarge on follow-up examination but otherwise
seldom causes further ocular complications5 – was
based on the tumour's location, size, shape, degree
of pigmentation and on ﬂuorescein angiography
characteristics. The latter tends to demonstrate hypo
ﬂuorescence in these lesions. A late pooling of dye
can be seen if secondary optic disc oedema and/or
subretinal ﬂuid are present.5 Ultrasonography is of
low diagnostic value because of the small size of
melanocytomas and the mean thickness of less than
1mm.5 Only 1–2% of ocular melanocytomas will
undergo transformation into melanoma.
Similar to choroidal melanocytomas, RPE neo-
plasms can present as dark brown or black lesions.4
RPE tumours appear as abruptly elevated masses
arising perpendicularly and usually lack the adjacent
base that is seen with most choroidal melanomas or
melanocytomas.4 It is reported that RPE adenomas
rest upon Bruch's membrane and do not produce
the characteristic mushroom conﬁguration of some
melanomas.4 However, RPE adenomas can induce
yellow retinal or subretinal exudation and ultimately
exudative retinal detachments.4 Tumours of the RPE
show prominent feeder vessels in arterial phase and
tend to be hypoﬂuorescent in the ﬁlling stages. This
is in contrast to choroidal melanomas, which show
a dilated tortuous vein and an early
hyperﬂuorescence and intense late staining.4 On ul-
trasound, RPE adenomas show high internal reﬂec-
tivity with A-scan and a dome-shaped mass with
acoustic hollowness with B-scan compared with the
low internal reﬂectivity of the choroidal melanoma.4
Figure 2. Immunohistochemical staining of the enucleated specimen. (a) Hematoxylin–eosin staining demonstrates the adenoma of
the RPE, with the adjacent disorganised retina showing gliosis (asterix) and occasional silicone oil droplets (arrows) (original magniﬁca-
tion ×20). (b) Immunostaining using AE1/AE3 indicates that the pigmented tumour has arisen from the RPE, which at the right has a reg-
ular structure (original magniﬁcation ×20). (c) The RPE adenoma demonstrated patchy immunoreactivity for MelanA (original
magniﬁcation ×40). (d) A very low Ki-67 growth fraction (arrow) (original magniﬁcation ×40).
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Cytological analysis demonstrates deeply pigmented,
plump, round cells with large melanosomes and rare
mitotic ﬁgures in RPE adenoma cases compared with
the spindle cells that characterize most melanomas.4,6
Because of its rarity, the immunohistochemical char-
acteristics of the RPE adenoma have not been exten-
sively described. In contrast to melanoma, RPE
adenoma is negative for HMB-45 and cytokeratin
7.6 Instead, RPE may be positive for epithelial mem-
brane antigen, S-100P, neurone-speciﬁc enolase,
synaptophysin and vimentin.6 To date, the genetic
changes of RPE adenomas are not known.
This case demonstrates the clinical complexity of
differentiating pigmented intraocular lesions as well
as the rarity of two different neoplastic entities in
the same eye. Further investigation of the molecular
and immunohistochemical features of RPE adenoma
would aid the diagnostic process in unclear cases
and enhance the therapeutic approach for the affected
patients.
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